Home hemodialysis (HHD) may offer improved health and quality of life for patients with end-stage kidney disease (ESKD), which affects more than 800,000 Americans. [i] However, due to patient fears ...
LAWRENCE, Mass., Aug. 28, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the U.S. Food and Drug ...
NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results